(NASDAQ: KMDA) Kamada's forecast annual revenue growth rate of 17.74% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,974.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,598.84%.
Kamada's revenue in 2026 is $174,787,000.On average, 5 Wall Street analysts forecast KMDA's revenue for 2026 to be $11,833,960,329, with the lowest KMDA revenue forecast at $11,274,436,378, and the highest KMDA revenue forecast at $12,280,774,420.
In 2027, KMDA is forecast to generate $12,779,918,089 in revenue, with the lowest revenue forecast at $12,076,631,560 and the highest revenue forecast at $13,267,560,752.